Дмитро

Dmytro Gerasymchuk

Final-stage doctoral researcher at the Faculty of Pharmacy, University of Helsinki, with over 15 years of
experience in the fields of allergy, molecular biology, and neuroscience spanning scientific communication,
technical writing, clinical trial monitoring, and allergy education.

Phone/WhatsApp: [відкрити контакти](див. вище в блоці «контактна інформація») (FI), [відкрити контакти](див. вище в блоці «контактна інформація») (UA)
E-mail: [відкрити контакти](див. вище в блоці «контактна інформація»)

Education
2023-2027 – PhD in Pharmacology, Faculty of Pharmacy, University of Helsinki, Finland.
2005-2007 – Master of Biology, National University “Kyiv-Mohyla Academy”, Kyiv, Ukraine.
2001-2005 – Bachelor of Biology, National University “Kyiv-Mohyla Academy”, Kyiv, Ukraine.

Work experience
Academic research and education
Non-Government Organization “Ukrainian School of Molecular Allergology and Immunology (USMAI)”,
Kyiv, Ukraine (remote)
Research Project Lead (Co-Lead)
October 2016 – Onwards
• Contributed to the organization and development of molecular allergy and immunology educational
courses for clinicians at the:
o NGO “Ukrainian School of Molecular Allergology and Immunology”
o Ukrainian Military Medical Academy
• Coordinated multi-year epidemiological research project involving Ukrainian military clinical population
cohort
• Managed multilateral international research and educational collaborations
• Oversaw data collection strategy and research reporting
• Contributed to study design, data analysis, and dissemination of study results.

University of Helsinki, Finland (on-site)
Doctoral Researcher / Visiting Researcher
June 2019 – Onwards
Research Projects:
• Effects of disturbed polyunsaturated fatty acid metabolism in Fragile X Syndrome (FXS) astrocytes
(manuscript accepted, October 2026).
• Trehalose-releasing nanogels reduce α-synuclein-induced Lewy body-like inclusions in primary mouse
hippocampal neurons (published in 2025).
• Role of microRNA miR-181 in the post-transcriptional regulation of human ITSN1 gene expression
(finalized).

Institute of Molecular Biology and Genetics, NAS of Ukraine, Kyiv, Ukraine
Junior Researcher
September 2008 – May 2019
Research Project:
• Regulation of human ITSN1 gene expression by microRNAs and RNA-binding proteins (publications –
2010, 2015).

Selected Coordination and Leadership Experience
• Collaborated and coordinated workflows with interdisciplinary teams across neurobiology, molecular
biology, and pharmacology
• Contributed to study design, experimental data analysis, and dissemination of research findings through
publications and scientific meetings
• Prepared and contributed to domestic and international grant applications supporting doctoral research
• Contributed to the organization of international scientific meetings, educational activities, and conferences
• Coordinated and supervised bachelor’s and master’s students.

Wet lab experimental expertise
• Molecular cloning and CRISPR/Cas9-based gene editing
• Generation and culturing of eukaryotic primary, continuous and human iPSC-derived cell lines
• qRT-PCR and basics of single-cell RNA sequencing
• Protein expression and purification: Western Blot analysis, immunohistochemistry, ELISA.

Data and scientific tools
• Fiji ImageJ
• Bio-Rad ImageLab
• Cell Profiler
• GraphPad Prism
• 10x Genomics Loupe Browser.

Industry
ROXALL Medizin GmbH, Hamburg, Germany (remote)
October 2022 – July 2024
Scientific Consultant (Molecular Allergy & Allergen-Specific Immunotherapy), Clinical Monitor
• Provided scientific and regulatory consulting for allergen-specific immunotherapy development
• Supported clinical trials monitoring and regulatory issues (Ukraine, Kazakhstan)
• Produced scientific documentation, reports, and translated clinical trials protocols and biomedical
publications for clinical use.

HVD Life Sciences GmbH, Vienna, Austria (hybrid)
March 2011 – February 2022
Scientific Consultant (Molecular Allergy Diagnostics)
• Produced scientific marketing documentation, translated marketing and scientific publications for
clinical use
• Contributed to the development of educational courses in allergy and immunology for clinicians within
the INUNIMAI online university project
• Generated scientific content for INUNIMAI social media platforms and website
• Acted as liaison between marketing team and clinical partners in Ukraine
• Presented INUNIMAI activities and educational initiatives at domestic and international conferences.

Received Grants and Scholarships
EDUFI Personal Scholarship (2019): 12-month funding to conduct research at Finnish universities
Finnish Parkinson’s Foundation Grant (2022)
Finnish Pharmaceutical Society Grant (2022)
DPDR/University of Helsinki Travel Grant for research visit to the Institute of Bioorganic Chemistry PAS, Poland
(2023).

Awards
Best Talk award, “It’s Pollen Time!” session, EAACI Congress 2026, Istanbul, Türkiye

Certificates
FELASA Functions A & D (2019)
IELTS Academic Level C1 (2021)

Languages
English – fluent, Ukrainian – native

Publications

1. Gerasymchuk D, Talvio K, House A, Meistermann D, Pospelov A, Kousa I, Ruhanen H, Koskuvi M,
Paavola J, Holopainen M, Ethell I, Koistinaho J, Käkelä R, Castren M. Astrocytes contribute to long-chain
polyunsaturated fatty acid metabolism affecting microglia in fragile X syndrome. iScience (Accepted).
2. Astrocytic GABA controls fidelity of temporal cortical processing in Fragile X Syndrome. Wagner VA,
Thapa R, Norman AO, Varallo A, Wimberly J, Rais M, Gerasymchuk D, Piepponen TP, Razak KA,
Castren ML, Ethell IM. Neurobiology of Disease (2026).
3. Maruf A, Gerasymchuk D, Hlushchuk I, Er S, Milewska M, Chmielarz P, Domanskyi A, Airavaara M,
Wandzik I. Trehalose-releasing nanogels reduce α-synuclein-induced Lewy body-like inclusions in
primary mouse hippocampal neurons. Journal of Material Chemistry B (2025).
4. Konovalova J, Gerasymchuk D, Arroyo SN, Kluske S, Mastroianni F, Pereyra AV, Domanskyi A. Human-
Specific Regulation of Neurotrophic Factors MANF and CDNF by microRNAs. International Journal of
Molecular Sciences (2021).
5. Gerasymchuk D, Hubiernatorova A, Domanskyi A. MicroRNAs Regulating Cytoskeleton Dynamics,
Endocytosis, and Cell Motility-A Link Between Neurodegeneration and Cancer? Frontiers in Neurology
(2020).
6. Konovalova J, Gerasymchuk D, Parkkinen I, Chmielarz P, Domanskyi A. Interplay between MicroRNAs
and Oxidative Stress in Neurodegenerative Diseases. International Journal of Molecular Sciences (2019).
7. Kropyvko SV, Gubar OS, Gryaznova TA, Morderer DY, Gerasymchuk DO, Syvak LA, Grabovoy AN,
Rynditch AV. Transcriptional and post-transcriptional regulation of the adaptor/scaffold protein gene
ITSN1. Biopolymers and Cell (2016).
8. Kropyvko S, Gerasymchuk D, Skrypkina I, Dergai M, Dergai O, Nikolaienko O, Rynditch A, Tsyba L.
Structural diversity and differential expression of novel human intersectin 1 isoforms. Molecular Biology
Reports (2010).

For the references, feel free to contact:
Prof. Mikko Airavaara, Faculty of Pharmacy, University of Helsinki, [відкрити контакти](див. вище в блоці «контактна інформація»)
Dr. Maija Castrén, Faculty of Medicine, University of Helsinki, [відкрити контакти](див. вище в блоці «контактна інформація»)
Dr. Andrii Domanskyi, Orion Pharma, [відкрити контакти](див. вище в блоці «контактна інформація»)